Agilent Technologies (NYSE:A) Updates FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 6.000-6.100 for the period, compared to the consensus earnings per share estimate of 5.970. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q3 2026 guidance to 1.480-1.500 EPS.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday. They set an “outperform” rating and a $153.00 target price for the company. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday. Morgan Stanley reduced their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Finally, Robert W. Baird upped their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $160.93.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $135.79 on Friday. The firm has a fifty day moving average price of $115.45 and a 200-day moving average price of $128.71. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market cap of $38.37 billion, a PE ratio of 27.27, a price-to-earnings-growth ratio of 2.44 and a beta of 1.22. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.74%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts anticipate that Agilent Technologies will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is 22.52%.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported Q2 earnings of $1.49 per share, topping estimates, while revenue rose 10% year over year to about $1.83 billion, reinforcing the company’s momentum in lab tools and research equipment.
• Positive Sentiment: The company raised its full-year FY 2026 profit forecast and also guided Q3 and FY 2026 results above or in line with consensus, which suggests management sees continued demand strength ahead.
• Positive Sentiment: Bank of America upgraded Agilent to Buy from Neutral, citing improving demand and market share gains, while TD Cowen, Barclays, and RBC also issued favorable ratings and higher price targets.
• Positive Sentiment: Several market recaps highlighted Agilent as one of the standout post-earnings movers, with investors responding positively to the company’s execution, margin growth, and recurring revenue mix.
• Neutral Sentiment: One analyst note still described the stock as a hold despite the strong quarter, suggesting some investors may wait for more confirmation that the improved trend can persist. Agilent Technologies: A Solid Q2 Beat, But The Stock Remains A Hold
• Neutral Sentiment: An industry comparison article and a product announcement about OpenLab Sync were more informational than stock-moving, with limited immediate impact on the shares. Agilent Technologies (NYSE:A) vs. Lonza Group (OTCMKTS:LZAGY) Head-To-Head Comparison Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

Institutional Trading of Agilent Technologies

Hedge funds and other institutional investors have recently modified their holdings of the company. Sivia Capital Partners LLC purchased a new position in Agilent Technologies during the second quarter valued at $273,000. Brighton Jones LLC grew its holdings in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares in the last quarter. IFC & Insurance Marketing Inc. purchased a new position in shares of Agilent Technologies in the fourth quarter valued at $155,000. SmartHarvest Portfolios LLC purchased a new position in shares of Agilent Technologies in the fourth quarter valued at $203,000. Finally, Zions Bancorporation National Association UT grew its holdings in shares of Agilent Technologies by 17.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock valued at $135,000 after purchasing an additional 145 shares in the last quarter.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.